1. Home
  2. GFAI vs GDTC Comparison

GFAI vs GDTC Comparison

Compare GFAI & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GFAI
  • GDTC
  • Stock Information
  • Founded
  • GFAI 2018
  • GDTC 2018
  • Country
  • GFAI Singapore
  • GDTC Singapore
  • Employees
  • GFAI N/A
  • GDTC N/A
  • Industry
  • GFAI Diversified Commercial Services
  • GDTC Biotechnology: Pharmaceutical Preparations
  • Sector
  • GFAI Consumer Discretionary
  • GDTC Health Care
  • Exchange
  • GFAI Nasdaq
  • GDTC Nasdaq
  • Market Cap
  • GFAI 23.3M
  • GDTC 21.5M
  • IPO Year
  • GFAI N/A
  • GDTC 2023
  • Fundamental
  • Price
  • GFAI $1.11
  • GDTC $1.83
  • Analyst Decision
  • GFAI Strong Buy
  • GDTC Buy
  • Analyst Count
  • GFAI 1
  • GDTC 1
  • Target Price
  • GFAI $4.50
  • GDTC $5.00
  • AVG Volume (30 Days)
  • GFAI 721.9K
  • GDTC 18.3K
  • Earning Date
  • GFAI 09-23-2025
  • GDTC 01-01-0001
  • Dividend Yield
  • GFAI N/A
  • GDTC N/A
  • EPS Growth
  • GFAI N/A
  • GDTC N/A
  • EPS
  • GFAI N/A
  • GDTC N/A
  • Revenue
  • GFAI $36,347,373.00
  • GDTC $368,838.00
  • Revenue This Year
  • GFAI $5.66
  • GDTC $5.37
  • Revenue Next Year
  • GFAI $4.69
  • GDTC N/A
  • P/E Ratio
  • GFAI N/A
  • GDTC N/A
  • Revenue Growth
  • GFAI 0.18
  • GDTC N/A
  • 52 Week Low
  • GFAI $0.76
  • GDTC $1.20
  • 52 Week High
  • GFAI $3.88
  • GDTC $4.05
  • Technical
  • Relative Strength Index (RSI)
  • GFAI 39.64
  • GDTC 33.59
  • Support Level
  • GFAI $1.27
  • GDTC $1.77
  • Resistance Level
  • GFAI $1.48
  • GDTC $1.95
  • Average True Range (ATR)
  • GFAI 0.11
  • GDTC 0.11
  • MACD
  • GFAI -0.03
  • GDTC -0.01
  • Stochastic Oscillator
  • GFAI 7.14
  • GDTC 15.69

About GFAI Guardforce AI Co. Limited

Guardforce AI Co Ltd is an integrated solution provider, specializing in security solutions, and also focuses on implementing AI and robotics solutions to improve business operational efficiency and sales and marketing processes, especially for the retail and travel industry in the Asia Pacific. The company's operating business segments include Secured Logistics, AI & Robotics Solution Business, General Security Solutions, and Corporate and others. A majority of its revenue is generated from the Secured Logistics segment, which includes services like cash-in-transit, dedicated vehicles to banks, ATM management, cash center operations, cash processing, coin processing, cheque center, and cash deposit machine solutions.

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

Share on Social Networks: